Cargando…

P124 Vaccination situation against COVID-19 in an adults cystic fibrosis center in Argentina

Detalles Bibliográficos
Autores principales:	Baran, E., Canonge, C., Zapitelli, G., D’Ascenzo, M.V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. Published by Elsevier B.V. 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250890/ http://dx.doi.org/10.1016/S1569-1993(23)00499-X

Ejemplares similares

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

P075 COVID-19 vaccination uptake in patients with cystic fibrosis
por: Manning, D.-E., et al.
Publicado: (2022)

66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
por: Ibarra, L., et al.
Publicado: (2015)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

P232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team
por: Jones, S., et al.
Publicado: (2021)

P146 COVID-19 pandemic in the Belgian cystic fibrosis patients compared with the international cystic fibrosis patients and the general Belgian population
por: Daneau, G., et al.
Publicado: (2023)

P077 Vaccination of patients with cystic fibrosis during the COVID-19 pandemic in Croatia
por: Markelić, I., et al.
Publicado: (2022)

P135 SARS-COV-2 infection in patients with cystic fibrosis
por: Balanetchi, L., et al.
Publicado: (2021)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

P088 Impact of COVID-19 and cocooning on employment of people with cystic fibrosis
por: Bhatnagar, R., et al.
Publicado: (2021)

P094 Facilitating cystic fibrosis research during the COVID-19 pandemic
por: Burnett, S., et al.
Publicado: (2021)

P095 Effect of age and genotype on lung function in children with cystic fibrosis
por: Shadrina, V., et al.
Publicado: (2021)

P119 Exploring the attitudes and knowledge of the caregivers of children with cystic fibrosis and primary ciliary dyskinesia regarding COVID-19 vaccination
por: Ergenekon, A.P., et al.
Publicado: (2023)

P076 COVID-19 vaccination in children and adolescents with cystic fibrosis - a single-centre experience
por: Zver, A., et al.
Publicado: (2022)

P084 The impact of the SARS-CoV-2 pandemic on people living with cystic fibrosis in Ireland: real-world data from the Irish cystic fibrosis registry
por: Rees, H., et al.
Publicado: (2021)

A82 PREVALENCE AND NON-INVASIVE SCREENING FOR CYSTIC FIBROSIS RELATED LIVER DISEASE IN A COHORT FOLLOWED AT A CYSTIC FIBROSIS REFERENCE CENTER
por: Coman, D E, et al.
Publicado: (2023)

P175 Extended incubation of cystic fibrosis cultures: is it worth it?
por: Amado, R., et al.
Publicado: (2019)

P087 Impact of COVID-19 on mental health of children with cystic fibrosis and their parents
por: Bhatnagar, R., et al.
Publicado: (2021)

P228 Concerns for people with cystic fibrosis when travelling pre-COVID-19
por: O'Doherty, M., et al.
Publicado: (2021)

P227 Cystic fibrosis social workers’ experience of working during COVID-19
por: Dowdall, F., et al.
Publicado: (2021)

P089 Coronavirus infection (COVID–19) in children with cystic fibrosis of the Russian Federation
por: Kondratyeva, E., et al.
Publicado: (2021)

44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study
por: Cheng, S., et al.
Publicado: (2021)

107: A new statewide consortium of cystic fibrosis care centers formed during the COVID-19 pandemic
por: Srinivasan, S., et al.
Publicado: (2021)

P086 The impact of COVID-19 in people with cystic fibrosis – a single-centre experience
por: Aldous, G., et al.
Publicado: (2021)

P091 Regularity of check-ups at the cystic fibrosis centre in the time of COVID-19 pandemic
por: Todorić, I., et al.
Publicado: (2021)

P085 Impact of COVID-19 on hospital services and specialist care of adults with cystic fibrosis
por: Bhatnagar, R., et al.
Publicado: (2021)

P136 Relationship between cystic fibrosis disease severity and susceptibility to COVID-19 infection
por: Atalay, M., et al.
Publicado: (2021)

P137 COVID-19 in cystic fibrosis patients with and without lung transplantation: the Zurich cohort
por: Steinack, C., et al.
Publicado: (2021)

P230 A review of paediatric cystic fibrosis care during the COVID-19 pandemic
por: Powell, L., et al.
Publicado: (2021)

P408 The effect of major life changes on exercise and physical activity in people with cystic fibrosis
por: Tomlinson, O.W., et al.
Publicado: (2023)

P074 Post-COVID-19 condition in children with cystic fibrosis
por: Chernyavskaya, A., et al.
Publicado: (2022)

P078 Adverse effects of Kaftrio® in an adult cystic fibrosis clinic
por: McCabe, D.
Publicado: (2022)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

491: Prospective Evaluation of nontuberculous mycobacterial Disease in Cystic fibrosis Trial (PREDICT): Colorado single center (2013–2018)
por: Martiniano, S., et al.
Publicado: (2021)

P226 A survey of family experience of cystic fibrosis care during the COVID-19 pandemic
por: Watkinson, J., et al.
Publicado: (2021)

P221 Quality of life in adult and children with cystic fibrosis during the COVID-19 pandemic in Croatia
por: Odobasic Palkovic, T., et al.
Publicado: (2021)

340: Challenges in obtaining COVID-19 vaccines: Bridging the gap for rural northeast Texas cystic fibrosis patients
por: Guthrie, C., et al.
Publicado: (2021)

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia
por: Bambir, I., et al.
Publicado: (2022)

666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle
por: Mukherjee, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3h7ss50ejh6vc50h125d9e2n1e